Novo Nordisk Stock Slides After Roche Strikes Weight-Loss Deal
In This Article:
Swiss pharmaceutical company Roche struck a multibillion-dollar collaboration and licensing deal with Zealand Pharma to co-develop a weight-loss treatment. Roche's stock rallied in Europe, while Zealand surged nearly 40%.